 "SME, liquidation")
Drug major Cipla on Saturday said it has voluntarily liquidated a wholly-owned step-down subsidiary.
This liquidation was a part of internal reorganisation and it will not affect performance or revenue of the company, Cipla said in a BSE filing.
"Cipla (UK) Ltd, a wholly owned subsidiary of Cipla (EU) Ltd and a wholly -owned step down subsidiary of the company, has been voluntarily liquidated with effect from March 5, 2021," the Mumbai-based drug firm said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
